×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RANI – rani therapeutics holdings, inc. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RANI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/19
04:55 pm
rani
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/19
04:05 pm
rani
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
3/17
12:20 pm
rani
Surf Therapeutics Reports Positive First-in-Human Data and Secures Additional Financing, Bringing Total Funding to $6M as Rheumatoid Arthritis Clinical Study Begins [Yahoo! Finance]
Low
Report
Surf Therapeutics Reports Positive First-in-Human Data and Secures Additional Financing, Bringing Total Funding to $6M as Rheumatoid Arthritis Clinical Study Begins [Yahoo! Finance]
1/28
10:48 am
rani
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer [Yahoo! Finance]
Medium
Report
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer [Yahoo! Finance]
1/28
07:00 am
rani
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
Medium
Report
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
1/9
08:02 am
rani
Rani Therapeutics (NASDAQ:RANI) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Low
Report
Rani Therapeutics (NASDAQ:RANI) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
1/8
07:00 am
rani
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen
Low
Report
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen
12/30
04:14 pm
rani
Rani Therapeutics (NASDAQ:RANI) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Neutral
Report
Rani Therapeutics (NASDAQ:RANI) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
8/7/2025
04:05 pm
RANI
rani therapeutics holdings, inc. - class a
BEAT
Report
-3.0%
rani therapeutics holdings, inc. - class a
5/13/2025
04:05 pm
RANI
rani therapeutics holdings, inc. - class a
IN-LINE
Report
17.0%
rani therapeutics holdings, inc. - class a
3/31/2025
04:05 pm
RANI
rani therapeutics holdings, inc. - class a
MISS
Report
-6.8%
rani therapeutics holdings, inc. - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/13
12:31 pm
rani
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: AWM Investment Company, Inc.
Medium
Report
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: AWM Investment Company, Inc.
2/12
01:45 pm
rani
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: SymBiosis Capital Partners, LLC
Low
Report
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: SymBiosis Capital Partners, LLC
1/30
02:44 pm
rani
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: VANGUARD GROUP INC
1/2
05:27 pm
rani
Form 8-K Rani Therapeutics Holdin For: Dec 31
Neutral
Report
Form 8-K Rani Therapeutics Holdin For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: